CYP2C9 and hepatocellular carcinoma: The protein levels of RRM2 and ATP6V1C1 were increased and that of FTCD and CYP2C9 were decreased in cancerous tissues compared to that in adjacent non-cancerous tissue in HCC patients (Figure 5a-h), and this is consistent with our bioinformatic analysis.